Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2026)

Adaptive Biotechnologies has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $2.7 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.7 million, changed 0.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (changed 0.07% YoY), and the FY2025 annual result was $1.2 million, down 47.22% from the prior year.
• Other Non-Current Assets came in at $2.7 million for Q1 2026 at Adaptive Biotechnologies, up from $1.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.4 million in Q2 2023 to a low of $874000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $2.6 million (2024), against an average of $2.5 million.
• Peak annual rise in Other Non-Current Assets reached 174.06% in 2022, while the deepest fall reached 58.38% in 2022.
• Adaptive Biotechnologies' Other Non-Current Assets stood at $2.4 million in 2022, then advanced by 20.93% to $2.9 million in 2023, then slipped by 21.14% to $2.3 million in 2024, then plunged by 47.22% to $1.2 million in 2025, then soared by 124.44% to $2.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.7 million (Q1 2026), $1.2 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.